MedTrace Logo

DOC Utility: Screening of Depression, Obstructive Sleep Apnea and Cognitive Impairment

NCT02363114 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 6500

Last updated 2021-09-22

No results posted yet for this study

Summary

The primary objective of this study is to determine whether baseline DOC screening can add to clinical and demographic data to predict the occurrence of a composite negative outcome (any of: recurrent stroke, myocardial infarction, death, or admission to a long-term care (LTC) / complex continuing care (CCC) facility) within one year of screening, in stroke prevention clinic patients.

Conditions

Sponsors & Collaborators

  • Canadian Institutes of Health Research (CIHR)

    collaborator OTHER_GOV

  • Dr. Richard H. Swartz

    lead OTHER

Principal Investigators

  • Richard H Swartz, MD, PHD · Sunnybrook Health Sciences Centre

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-04-01
Primary Completion
2017-09-30
Completion
2022-12-01

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02363114 on ClinicalTrials.gov